Impact of changed co-amoxiclav susceptibility testing formats on apparent resistance rates for bloodstream Escherichia coli in a long-term surveillance-Reference-Cited by-同舟云学术

Impact of changed co-amoxiclav susceptibility testing formats on apparent resistance rates for bloodstream Escherichia coli in a long-term surveillance

Published:2022-01-19 Issue: Volume: Page:
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Reynolds Rosy¹,Mushtaq Shazad²,Allen Michael K.³,Horner Carolyne⁴,Longshaw Christopher⁵,Livermore David M.⁶

Affiliation:

1. Bristol Medical School, University of Bristol, Bristol, UK

2. UK Health Security Agency, London, UK

3. Merck Sharp & Dohme (UK) Limited, London, UK

4. BSAC, Birmingham, UK

5. Shionogi B.V., London, UK

6. University of East Anglia, Norwich, UK

Funder

NIHR

University of Bristol

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

https://academic.oup.com/jac/advance-article-pdf/doi/10.1093/jac/dkab483/42243663/dkab483.pdf

Reference5 articles.

1. Survey, laboratory and statistical methods for the BSAC Resistance Surveillance Programmes;Reynolds;J Antimicrob Chemother,2008

2. Performance of EUCAST and CLSI approaches for co-amoxiclav susceptibility testing conditions for clinical categorization of a collection of Escherichia coli isolates with characterized resistance phenotypes;Diez-Aguilar;J Antimicrob Chemother,2015

3. Consequences of switching from a fixed 2:1 ratio of amoxicillin/clavulanate (CLSI) to a fixed concentration of clavulanate (EUCAST) for susceptibility testing of Escherichia coli;Leverstein-van Hall;J Antimicrob Chemother,2013

4. MIC of amoxicillin/clavulanate according to CLSI and EUCAST: discrepancies and clinical impact in patients with bloodstream infections due to Enterobacteriaceae;Delgado-Valverde;J Antimicrob Chemother,2017

5. English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR). Report 2019 to 2020;UKHSA